title: COPD is associated with reduced pulmonary interstitial expression of pentraxin-3.
abstract: Pentraxin (PTX)3 is involved in antimicrobial defence, apoptotic cell clearance and extracellular matrix stability. As these processes are altered in chronic obstructive pulmonary disease (COPD), we aimed to investigate PTX3 expression in patients with this disease. PTX3 expression was quantified by immunohistochemical staining of lung tissue from never-smokers, smokers without COPD, and in patients with COPD of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage I, II and III-IV. mRNA expression was examined in total lung tissue by quantitative RT-PCR. PTX3 concentration was measured in induced sputum and plasma by ELISA. PTX3 is mainly localised in the interstitium of the small airways and alveolar walls. There were no significant differences in pulmonary, sputum and plasma PTX3 expression between study groups. However, PTX3 expression in small airways correlated significantly with forced expiratory volume in 1 s (r = 0.35, p = 0.004). In the alveolar walls, PTX3 expression correlated significantly with carbon monoxide transfer coefficient (r = 0.28, p = 0.04). In sputum, PTX3 levels were highly correlated with the number of neutrophils. Finally, systemic levels of PTX3 tended to be lower in severe COPD compared with mild COPD. In COPD, airflow limitation and reduced transfer coefficient for carbon monoxide are associated with lower pulmonary interstitial expression of PTX3.
authors.affiliation: Dept of Respiratory Medicine, Ghent University Hospital, 7K12 IE, De Pintelaan 185, B9000 Ghent, Belgium. geert.vanpottelberge@ugent.be
authors.forename: G R
authors.initials: GR
authors.lastname: Van Pottelberge
authors.forename: K R
authors.initials: KR
authors.lastname: Bracke
authors.forename: N S
authors.initials: NS
authors.lastname: Pauwels
authors.forename: F E
authors.initials: FE
authors.lastname: Vermassen
authors.forename: G F
authors.initials: GF
authors.lastname: Joos
authors.forename: G G
authors.initials: GG
authors.lastname: Brusselle
mesh_terms: D000328:Adult; D000368:Aged; D055745:Bronchioles / Q000502:physiology; D002097:C-Reactive Protein / Q000235:genetics* / Q000378:metabolism; D005260:Female; D006801:Humans; D008168:Lung / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000502:physiology; D011651:Pulmonary Artery / Q000502:physiology; D029424:Pulmonary Disease, Chronic Obstructive / Q000378:metabolism / Q000503:physiopathology*; D012333:RNA, Messenger / Q000378:metabolism; D020545:Respiratory Mucosa / Q000502:physiology; D000683:Serum Amyloid P-Component / Q000235:genetics* / Q000378:metabolism; D012907:Smoking / Q000378:metabolism / Q000503:physiopathology; D013183:Sputum / Q000378:metabolism; D000099153:Pentraxins
chemical_list: D002097:C-Reactive Protein; D012333:RNA, Messenger; D000683:Serum Amyloid P-Component; D000099153:Pentraxins